Noom Med vs Hims GLP-1: The Honest 2026 Comparison (Cost, Meds & Best Fit)
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We have affiliate relationships with some providers mentioned as alternatives on this page (Eden, Ro). We do not have an affiliate relationship with Hims or Noom. Our comparison between these two is editorially neutral. See the full disclosure and methodology section below.
If you're comparing Noom Med vs Hims GLP-1 for weight loss, here is the short answer before you scroll any further.
Pick Hims if:
You want a simple cash-pay path to FDA-approved brand-name medication — Wegovy® pill, Wegovy® pen, Zepbound® vial or KwikPen®, Foundayo™, or Ozempic® — with no coaching app to manage. First month: $39 membership + medication from $149 = $188+ starter. After that: $149/month membership + medication.
Pick Noom Med if:
You want compounded semaglutide, a microdose option, or a psychology-based coaching program bundled with the medication. Noom's GLP-1Rx pricing: $129 to start, then $279/month billed as $837 every 12 weeks; GLP-1Rx Plus: $149 to start, then $299/month billed quarterly; Microdose: $79 to start, then $179–$199/month billed quarterly. ⚠️ Noom's own pages show different numbers on different pages — verify at checkout.
Here is what almost every other comparison page misses: Hims dropped compounded semaglutide for new patients in March 2026, and Noom runs multiple programs all marketed under the Noom Med umbrella — each with different pricing, different medications, and different billing cycles. If you compare the wrong programs, you will make the wrong decision.
✓ What We Verified For This Page
We treated this like a real shopping trip. Every price, medication, and policy below was checked against primary sources on May 14, 2026. Here is the receipt.
- ✓Hims weight-loss and medication pricing: hims.com/weight-loss, hims.com/weight-loss/drug-pricing, hims.com/weight-loss/wegovy, hims.com/weight-loss/zepbound-vial, hims.com/weight-loss/zepbound-kwikpen
- ✓Hims FAQ and cancellation policy: hims.com/weight-loss/faq and support.hims.com
- ✓Noom Med pricing and program tiers: noom.com/med, noom.com/med/pricing, noom.com/med/glp-1rx, noom.com/med/microdose-glp1-rx, noom.com/blog/weight-management/noom-cost
- ✓Noom refund and cancellation policy: noom.com/support
- ✓Hims–Novo Nordisk March 2026 partnership and Hims–Eli Lilly April 2026 expansion — official press releases from both companies
- ✓FDA approval of Foundayo™ (orforglipron) — fda.gov, April 1, 2026
- ✓FDA approval of Wegovy® HD 7.2mg — fda.gov, March 19, 2026
- ✓FDA proposed rule excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list — fda.gov April 30, 2026; Federal Register May 1, 2026
The Quick Verdict: Noom Med vs Hims GLP-1 at a Glance
Hims is now an FDA-approved-only platform. Noom is still primarily a compounded GLP-1 provider with a coaching program built around the medication. All prices verified May 14, 2026. ⚠️ marks figures where Noom's own pages list different numbers.
| Hims (GLP-1) | Noom Med (GLP-1Rx) | |
|---|---|---|
| First-month cost | $39 membership + $149+ medication = $188+ starter | $129–$149 starter (includes compounded medication) ⚠️ |
| Ongoing monthly cost | $149 membership + $149–$1,899 medication | $279–$299/month billed $837–$897 every 12 weeks ⚠️ |
| Microdose option | ❌ Not offered | ✅ $79 first, then $179–$199/month ⚠️ |
| Compounded semaglutide (new patients) | ❌ Discontinued March 2026 | ✅ Yes |
| Compounded tirzepatide | ❌ Not offered | ✅ Via GLP-1Rx Plus |
| FDA-approved Wegovy® pill | ✅ From $149/month | ✅ Via Telehealth for Branded Meds (pharmacy fill, separate cost) |
| FDA-approved Wegovy® injection | ✅ From $199/month | ✅ Via Telehealth for Branded Meds |
| FDA-approved Zepbound® | ✅ From $199/month | ✅ Via Telehealth for Branded Meds |
| FDA-approved Foundayo™ | ✅ $149/month | ❌ Not currently on Noom GLP-1Rx menu |
| Bundled coaching curriculum | Light support, app-based tracking | ✅ Daily psychology lessons, food logging, group coaching |
| Insurance / Medicare | Cash-pay only; insurance not required | Insurance navigation available for branded medications |
| HSA / FSA | Submit receipt to your administrator | ✅ Marked HSA/FSA eligible on most plans |
| State availability | Not available in all 50 states | Compounded GLP-1Rx not available in AL, LA, MS |
| Cancel anytime | Yes — canceling membership cancels medication access | Yes — compounded plans bill in 12-week lumps; no refund once prescribed |
All prices verified May 14, 2026 from each platform's official site. Pricing changes often — confirm the current rate before signing up.
Not sure which one fits you yet?
Take our free 60-second matching quiz — we'll point you to the right path based on your insurance, state, budget, and medication preference.
Take the Free 60-Second Quiz →What Changed in 2026: Why This Comparison Looks Nothing Like Last Year's
If you read a Noom-vs-Hims article from before March 2026, throw it out. Here are the six shifts that decide your choice this year.
1. Hims and Novo Nordisk struck a deal (March 9, 2026)
Hims and Novo Nordisk fought publicly through most of 2025 — Novo even sued Hims over compounded semaglutide. That ended on March 9, 2026, when both companies announced a long-term partnership. Hims agreed to stop advertising compounded semaglutide to new patients, and Novo agreed to sell FDA-approved Wegovy® and Ozempic® through Hims at competitive cash-pay prices.
2. Hims added Eli Lilly's GLP-1 lineup too (April 23, 2026)
Less than two months after the Novo deal, Hims announced that Eli Lilly's Zepbound®, Mounjaro®, and Foundayo™ were available on the platform (source: Hims investor newsroom, April 23, 2026). Hims now lists Zepbound starting at $199/month, Foundayo at $149/month, and Mounjaro at $1,899/month — alongside Novo's Wegovy and Ozempic — giving it a broad FDA-approved GLP-1 menu under one membership.
3. Noom reset its pricing on March 31, 2026
Noom updated pricing for all new accounts effective March 31, 2026. The numbers vary by program — and Noom's own published pages still do not fully agree with each other:
- Microdose GLP-1Rx: $79 first 4-week supply, then $179–$199/month billed quarterly ⚠️
- GLP-1Rx (standard dose): $129 first 4-week supply, then $279/month billed as $837 every 12 weeks ⚠️
- GLP-1Rx Plus: $149 first 4-week supply, then $299/month billed quarterly
- Telehealth for Branded Meds: $69 first month, then $99/month — medication filled separately at pharmacy
- Weight-Loss Pill (metformin): $99/month
4. Foundayo™ became the first FDA-approved oral GLP-1 for weight loss (April 1, 2026)
Foundayo (orforglipron) is the first non-peptide oral GLP-1 ever approved by the FDA for chronic weight management. It launched April 6, 2026 through LillyDirect and is now also available on Hims at $149/month. Noom's current GLP-1Rx medication menu does not list Foundayo. Other major telehealth platforms also carry it, including Ro.
5. FDA proposed to exclude compounded GLP-1s from the 503B bulks list (April 30, 2026)
On April 30, 2026, the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list — the list that lets large outsourcing pharmacies legally compound those drugs from raw materials (source: fda.gov press announcement, April 30, 2026; Federal Register, May 1, 2026). The public comment period closes June 29, 2026.
6. Wegovy® HD 7.2mg was approved (March 19, 2026)
FDA approved a new higher dose of Wegovy — 7.2mg, called Wegovy HD — on March 19, 2026. Per Novo Nordisk, it is intended for adults who have tolerated the 2.4mg dose for at least four weeks and need additional weight reduction. Available at Hims as part of the injectable Wegovy lineup.
Which Noom Med Program Is Actually Comparable to Hims?
Noom Med is not one product. It is an umbrella that covers several programs, each with its own price, billing cadence, medication, and target user. Comparing the wrong Noom program to Hims is the #1 reason people end up confused. Here is the decoder built from Noom's own published pages.
Noom Weight (the original app — NOT a GLP-1 program)
This is the Noom most people remember from old commercials. It is a behavior-change app with daily psychology lessons, food logging, and group coaching. No prescriptions. No GLP-1. It costs about $17/month on an annual plan.
This is not what you are comparing to Hims. But it is worth knowing it exists — Noom's marketing sometimes blurs the line between the app and the medical programs.
Noom Telehealth for Branded Meds — Closest to Hims
$69 first month, then $99/month
Includes: clinician access, insurance navigation for branded GLP-1s, the Noom app. Does not include the medication itself — you fill the prescription at your pharmacy and pay separately.
This is closest to a direct comparison with Hims. Both prescribe FDA-approved medication. The big difference: Hims publishes a fixed cash price ($149 for Wegovy pill, etc.). With Noom Telehealth, your medication cost depends on your pharmacy and your insurance.
Noom Microdose GLP-1Rx Program
$79 first 4-week supply, then $179–$199/month billed quarterly ⚠️
Compounded semaglutide at lower-than-standard doses. Designed for people who want to reduce side effects or ease in slowly.
Hims does not offer a microdose program. If you want a gentler entry and fewer side effects, Microdose is one of Noom's biggest differentiators between these two platforms.
Noom GLP-1Rx (standard dose, compounded)
$129 first 4-week supply, then $279/month billed as $837 every 12 weeks ⚠️
Standard-dose compounded semaglutide. This is the path you would have compared to the old Hims compounded plan — which no longer exists for new patients.
Noom GLP-1Rx Plus (compounded tirzepatide path)
$149 first 4-week supply, then $299/month billed quarterly
Per Noom's own support FAQ, GLP-1Rx Plus is the program that offers compounded tirzepatide by prescription, with availability varying by location. Standard compounded semaglutide is also available depending on the clinician's plan.
If you specifically want compounded tirzepatide between these two platforms, this is the Noom tier — Hims doesn't offer compounded tirzepatide at all.
Noom Weight-Loss Pill (metformin)
$69 to start, $99/month after — metformin, an older diabetes drug sometimes used off-label for weight loss. Not a GLP-1 — fundamentally different medication. Listed here so you don't pick it by mistake at checkout.
Note: Throughout this guide, "Noom" means Noom's compounded GLP-1Rx tier unless we specifically call out Microdose, GLP-1Rx Plus, or Telehealth for Branded Meds.
What GLP-1 Medications Can You Get Through Hims Now?
Hims is now a cash-pay FDA-approved GLP-1 platform with a broad menu under one membership. Following its 2026 partnerships with Novo Nordisk and Eli Lilly, Hims lists Wegovy, Zepbound, Mounjaro, Ozempic, Foundayo, and Ozempic pill on its weight-loss platform.
| Medication | Form | Hims cash price | FDA indication |
|---|---|---|---|
| Wegovy® Pill | Daily oral | From $149/month | ✅ Weight management |
| Wegovy® Pen (all doses incl. HD 7.2mg) | Weekly injection | From $199/month | ✅ Weight management |
| Zepbound® Vial | Weekly injection | From $199/month (dose-dependent) | ✅ Weight management |
| Zepbound® KwikPen® | Weekly injection | From $199/month (dose-dependent) | ✅ Weight management |
| Foundayo™ | Daily oral | $149/month | ✅ Weight management |
| Ozempic® Pill | Daily oral | From $149/month | Off-label for weight loss; FDA-approved for type 2 diabetes |
| Mounjaro® | Weekly injection | $1,899/month | Off-label for weight loss; FDA-approved for type 2 diabetes |
Verified May 14, 2026 from hims.com/weight-loss and hims.com/weight-loss/drug-pricing. Prices are cash-pay, before tax. Hims says GLP-1 services are not available in all 50 states — verified during intake.
Cross-Platform Medication Matrix
Which medications can you actually get on each platform? Built from published materials on May 14, 2026.
| Medication | Hims | Noom Med |
|---|---|---|
| Compounded semaglutide (standard injection) | ❌ Not for new patients | ✅ GLP-1Rx, from $129 first month then $279/month quarterly ⚠️ |
| Compounded semaglutide (microdose) | ❌ Not offered | ✅ Microdose, from $79 first month then $179–$199/month quarterly ⚠️ |
| Compounded tirzepatide | ❌ Not offered | ✅ GLP-1Rx Plus, $149 first month then $299/month quarterly |
| Compounded oral / sublingual GLP-1 | ❌ Not offered | ❌ Not offered |
| Wegovy® Pill (FDA-approved oral semaglutide) | ✅ From $149/month | ✅ Telehealth for Branded Meds (pharmacy fill, separate cost) |
| Wegovy® Pen (all doses incl. HD 7.2mg) | ✅ From $199/month | ✅ Telehealth for Branded Meds |
| Zepbound® Vial / KwikPen® (FDA-approved tirzepatide) | ✅ From $199/month | ✅ Telehealth for Branded Meds |
| Ozempic® (FDA-approved for T2D; off-label weight loss) | ✅ Pill form from $149/month | ✅ Telehealth for Branded Meds |
| Mounjaro® (FDA-approved for T2D; off-label weight loss) | ✅ $1,899/month | ✅ Telehealth for Branded Meds |
| Foundayo™ (FDA-approved oral non-peptide GLP-1) | ✅ $149/month | ❌ Not currently on Noom GLP-1Rx menu |
| Metformin (off-label for weight loss) | ✅ In personalized oral kits | ✅ Weight-Loss Pill plan, $99/month |
• If you need compounded semaglutide or tirzepatide — Noom is the only answer between these two. Hims no longer offers these.
• If you need Foundayo™ — Hims is the only answer between these two.
• If you need a microdose program — Noom is the only option. Hims doesn't offer this.
• If you want brand-name Wegovy or Zepbound at a fixed cash price — Hims publishes the number. Noom Telehealth's medication cost depends on your pharmacy.
How Much Does Noom Med vs Hims GLP-1 Cost Over 12 Months?
Intro prices are designed to grab you. What matters is what you'll pay in month 6 and month 12. We ran the math on four common scenarios. All numbers verified May 14, 2026. Cash-pay, no insurance reimbursement, no manufacturer savings cards applied.
Scenario 1: Standard-dose compounded semaglutide for one year
| Hims | Noom GLP-1Rx | |
|---|---|---|
| Available for new patients? | ❌ No (discontinued March 2026) | ✅ Yes |
| First 4-week supply | N/A | $129 ⚠️ |
| 12-week renewal cycles ×4 | N/A | $837 × 4 = $3,348 |
| 52-week planning total | N/A | ~$3,477 ⚠️ |
Verdict: This is not head-to-head anymore — Noom is the only path between these two for compounded semaglutide. ⚠️ Noom's pricing pages disagree on whether the renewal is $279/$837 or $299/$897. Verify at checkout. For lower-priced compounded options, see the alternatives section — Eden lists flat-rate compounded semaglutide at competitive pricing.
Scenario 2: Compounded semaglutide microdose for one year
| Hims | Noom Microdose | |
|---|---|---|
| Available? | ❌ No microdose program | ✅ Yes |
| First 4-week supply | N/A | $79 |
| 12-week renewal cycles ×4 | N/A | $537–$597 × 4 = $2,148–$2,388 ⚠️ |
| 52-week planning total | N/A | ~$2,227–$2,467 ⚠️ |
Verdict: Microdose is a Noom-only path between these two. If you want lower-dose GLP-1 with potentially fewer side effects, Noom Microdose is one of the few mainstream programs designed around it. ⚠️ Renewal price varies $179–$199/month on Noom's own pages — verify at checkout.
Scenario 3: FDA-approved Wegovy® pill for one year (cash pay)
| Hims | Noom Telehealth for Branded Meds | |
|---|---|---|
| Month 1 — Program / membership fee | $39 | $69 |
| Month 1 — Medication | $149 (fixed cash price) | Pharmacy cash price (varies) |
| Month 1 total | $188 | $69 + pharmacy medication cost |
| Months 2–12 — Program / membership | $149 × 11 = $1,639 | $99 × 11 = $1,089 |
| Months 2–12 — Medication | $149 × 11 = $1,639 | Pharmacy cost × 11 |
| 52-week program-fee total | $1,678 | $1,158 |
| 52-week medication total at $149/mo | $1,788 | Pharmacy-dependent |
| Combined annual planning floor | ~$3,466 | ~$1,158 + verified pharmacy cost |
Verdict: For brand-name Wegovy pill, Noom's program-fee total is about $520/year lower than Hims. But Hims publishes a fixed $149/month cash medication price; Noom Telehealth leaves the medication cost up to your pharmacy. If you have insurance or a pharmacy that beats $149, Noom can be cheaper. If you don't, Hims's published cash price gives you a number you can plan around.
Scenario 4: FDA-approved Zepbound® for one year (cash pay)
| Hims | Noom Telehealth for Branded Meds | |
|---|---|---|
| Month 1 — Program / membership fee | $39 | $69 |
| Month 1 — Zepbound (2.5mg starter floor) | $199 | Pharmacy cash price (varies) |
| Month 1 total | $238 | $69 + pharmacy medication cost |
| Months 2–12 — Program / membership | $149 × 11 = $1,639 | $99 × 11 = $1,089 |
| 52-week program-fee total | $1,678 | $1,158 |
| 52-week medication floor at $199/mo | $2,388 | Pharmacy-dependent |
| Combined annual planning floor (2.5mg) | ~$4,066 | ~$1,158 + verified pharmacy cost |
Verdict: Zepbound pricing scales with dose on both platforms. The $199/month Hims rate is the 2.5mg starter floor — higher doses move into the $299–$499 range. Noom Telehealth's medication cost depends on the dispensing pharmacy. For a budget-confident annual plan on cash pay, Hims publishes the number; with Noom, you will need a pharmacy quote.
The pattern that matters:
• Compounded semaglutide and microdose: Noom by default — Hims doesn't offer these.
• FDA-approved brand-name medications: Noom's program fee is cheaper, but Hims publishes a fixed medication price you can plan around.
• Foundayo™: Hims is the path. Noom doesn't currently list Foundayo on the GLP-1Rx menu.
• Cheapest compounded path overall: See alternatives section below.
Want to skip the math?
Take our free 60-second GLP-1 matching quiz — we'll match you to the program that fits your insurance, state, and medication preference in under a minute.
Take the Free 60-Second Quiz →Damaging Admission: One Real Tradeoff With Hims
The honest catch with Hims's new 2026 platform:
Hims does not offer any compounded GLP-1 path for new patients, no microdose option, and no compounded tirzepatide.
If you came here looking for cheap compounded semaglutide, compounded tirzepatide, or a gentle low-dose entry point, Hims is not your platform anymore. If that is your priority, Noom Med wins this comparison outright between these two — and Eden may be an even better fit (see alternatives below).
Which One Fits You? 7 Scenarios
Pick the scenario that matches your situation.
I want compounded semaglutide at the lowest cash-pay price.
→ Pick Noom
I want FDA-approved brand-name GLP-1 at a fixed cash price I can budget around.
→ Pick Hims
I want Foundayo™ (the new FDA-approved oral GLP-1 pill, orforglipron).
→ Pick Hims
I want a microdose or gentle low-dose entry to minimize side effects.
→ Pick Noom
I have commercial insurance and want help getting it covered.
→ Pick Noom (for the program fee) then check Ro
I want maximum coaching, behavior change, and accountability.
→ Pick Noom
I want compounded tirzepatide.
→ Pick Noom GLP-1Rx Plus
Is Noom Med or Hims Available in My State?
State availability is the quietest dealbreaker in this comparison. Most articles ignore it. Both platforms have state limits that can change your real options before you ever see a checkout page.
Hims
Hims explicitly notes that its GLP-1 offering is not available in all 50 states, and some states require a brief live audio or video visit before prescribing. Specific exclusions are not published — state availability and visit requirements are confirmed during intake.
Noom Med
Noom GLP-1Rx (compounded) is available in all U.S. states except Alabama, Louisiana, and Mississippi. Noom Telehealth for Branded Meds is available more broadly. Specific compounded formulations or tiers may have additional restrictions — verify during intake.
Can You Cancel Noom Med or Hims Without Losing Money?
Both platforms let you cancel anytime, but the billing structures behind each create different surprises. Here is the real picture.
Hims: How cancellation actually works
- •You can cancel anytime from your account.
- •Canceling your Weight Loss Membership cancels your medication plan and access to care through Hims.
- •Canceling only the medication plan does NOT cancel the membership — the $149/month membership keeps billing unless you cancel it separately.
- •Medication is billed separately, monthly or upfront depending on your specific plan.
- •Multi-month bundled offers (Hims occasionally promotes 6-month Wegovy plans paid upfront) — refunds depend on terms agreed at checkout.
- •Complete cancellation at least 2 days before your next billing date.
Noom: How cancellation actually works
- •You can cancel anytime from your account.
- •A refund may be available if no prescription has been written; once the prescription is written, no refund is available.
- •Renewal charges are not refundable. If you've already entered a new 12-week cycle, you've paid for that cycle.
- •GLP-1Rx, GLP-1Rx Plus, and Microdose bill in 12-week lumps ($537–$897 per cycle). Canceling mid-cycle means medication continues through the end of the paid cycle, then service stops.
- •If you switch between Noom Med programs, Noom says a prorated refund may apply in some cases, but shipped or in-process medication can't be refunded.
Practical takeaway: If month-to-month flexibility matters to you, Hims's billing is easier to exit cleanly. Noom's 12-week billing fits committed users but is not great for "I want to try one month and decide." If quarterly billing is a dealbreaker, see the alternatives section below — there are month-to-month compounded providers we recommend.
What Do Real Hims and Noom Users Say?
We don't believe in fabricated reviews. Here are real, attributable quotes from each platform's published materials, with sources cited so you can read them in full.
Hims customers
"I chose Hims because it seemed to have the full package of what I was looking for — the weight loss supplement at a reasonable price, a doctor or nurse practitioner I can meet with regularly whenever I needed to."
"I went from XL shirts to Medium. Just amazing. It was a wild feeling to never have that urge to snack or want a second helping. The other impact? I have more energy than ever."
Per Hims's own disclosure, testimonial participants may have been compensated, results have not been independently verified, and individual results vary. Older testimonials may also reflect experiences with compounded GLP-1s no longer offered to new patients.
Noom self-reported outcome data
These are top-25th-percentile self-reported outcomes from internal Noom user samples, not average results and not independent clinical trial data. Source: noom.com/med/pricing.
- • Top 25th percentile of 1,597 Noom Med users (Full-Dose compounded): average weight loss of 25 pounds
- • Top 25th percentile of 1,185 Noom Med users (Microdose compounded): average weight loss of 13 pounds
- • Noom states users lose 48% more weight in 6 months compared to those taking GLP-1 medications without Noom's behavior-change program, based on a retrospective self-reported study of 387 participants
Compounded medication outcomes cannot be directly compared to FDA-approved Wegovy or Zepbound clinical trial outcomes — compounded products are not reviewed by the FDA for safety, effectiveness, or quality.
Best Alternatives If Neither Fits
You came here to compare Noom Med and Hims. If the breakdown above showed you that neither is your ideal path, here are the two providers we would genuinely point a friend to — disclosed honestly as affiliate partners — based on what you actually need.
If you want compounded semaglutide with HSA/FSA flagged and no membership fee → Eden
Eden is one of the strongest broad-default compounded providers in 2026: no membership fee, HSA/FSA flagged on every plan, flat pricing at every dose, and a broad cash-pay menu including options Noom doesn't currently offer. If you wanted the old Hims compounded plan and that path is gone, Eden is the closest like-for-like replacement we recommend.
See Eden's Current Pricing →If you have commercial insurance and want help getting GLP-1 coverage → Ro
Ro has one of the most thorough insurance navigation systems in the telehealth GLP-1 space — including prior authorization assistance, appeals support, and access to FDA-approved Wegovy, Zepbound, and Foundayo. If insurance coverage is your primary goal and you're not getting it through Noom or Hims, Ro is a strong alternative worth checking first.
See Ro's Current Pricing →You've read the breakdown. Still on the fence?
Take the free 60-second GLP-1 matching quiz. No email required to see your match. No upsell. Just a clear next step based on your insurance, your state, your budget, and the medication you want.
Take the Free 60-Second Quiz →About This Article & Methodology
Author
Weight Loss Provider Guide Editorial Team. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.
Last verified
May 14, 2026. Next scheduled review: June 14, 2026 — or sooner if any of these triggers occurs: Hims or Noom pricing change, new FDA-approved GLP-1 medication, FDA enforcement action, Medicare GLP-1 Bridge program launch, or final FDA action on the 503B bulks list proposal.
What we checked on May 14, 2026
- Official pricing pages: hims.com/weight-loss/drug-pricing and noom.com/med
- Membership/subscription terms: hims.com/weight-loss/faq and hims.com/terms-and-conditions
- Noom program-specific pages: noom.com/med, noom.com/med/glp-1rx, noom.com/med/microdose-glp1-rx, noom.com/blog/weight-management/noom-cost
- Hims medication pages: hims.com/weight-loss/wegovy, hims.com/weight-loss/zepbound-vial, hims.com/weight-loss/zepbound-kwikpen
- Hims–Novo Nordisk March 2026 partnership and Hims–Eli Lilly April 2026 expansion (official press releases)
- FDA approval of Foundayo™ (orforglipron) — fda.gov, April 1, 2026
- FDA approval of Wegovy® HD 7.2mg — fda.gov, March 19, 2026
- FDA proposed rule on 503B bulks list — fda.gov April 30, 2026; Federal Register May 1, 2026
- Cancellation/refund policies: Published terms on both platforms
- State availability: noom.com/med/glp-1rx (AL, LA, MS exclusions confirmed)
Affiliate disclosure
Weight Loss Provider Guide may earn a commission if you sign up with Eden or Ro through links on this page. We do not have an affiliate relationship with Hims or Noom. Our comparison between Hims and Noom is editorially neutral and not influenced by any commercial relationship. Commissions never affect our recommendations — we recommend providers based on verified evidence, reader fit, and the criteria documented above.
Medical disclaimer
This article is for informational purposes only. It is not medical advice. GLP-1 medications carry serious risks and are not appropriate for everyone. Always consult a licensed healthcare provider before starting or stopping any prescription medication, including GLP-1 receptor agonists. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, and KwikPen® are registered trademarks of Eli Lilly and Company. Foundayo™ is a trademark of Eli Lilly and Company. Weight Loss Provider Guide is not affiliated with or endorsed by Novo Nordisk, Eli Lilly, Hims & Hers Health, or Noom.
Noom Med vs Hims GLP-1: Frequently Asked Questions
Still Not Sure Which GLP-1 Program Is Right for You?
If you read this entire comparison and your answer is still "I'm not sure" — that is a reasonable place to be. Both Hims and Noom are legitimate options for specific situations. But the best fit for your budget, your insurance status, your medication preference, and your lifestyle might not be either one.
Take our free 60-second matching quiz — answer 5 quick questions and we'll show you the 2–3 providers that actually fit your situation.
Find My GLP-1 Path → Take the Quiz